Until this study, the role of CSF2 in PD/DLB and other neurodegenerative disorders had not been considered; however, increased levels of CSF-R1 have been described in AD and inhibitors of CSF-R1 have been proposed as a therapy for PD and other neurodegenerative disorders [90]. Here, CSF2 is linked to Parkinson disease.